New Era Stroke Care and Research Institute, The PLA Rocket Force Characteristic Medical Center, Beijing, China.
Department of Radiotherapy, The PLA Rocket Force Characteristic Medical Center, Beijing, China.
Brain Behav. 2023 Dec;13(12):e3260. doi: 10.1002/brb3.3260. Epub 2023 Nov 8.
OBJECTIVES: To date, the effectiveness of acceptance and commitment therapy (ACT) for acute stroke patients has not been well recognized. The study aimed to discover the effectiveness of group-based ACT in treating depression for acute stroke patients. METHODS: We conducted a randomized controlled trial with 140 acute stroke patients with depression. The ACT intervention comprised seven sessions, of 45-60 min over 4 weeks. Data were collected pre- and post-intervention and at 3-month follow-up, assessing depression, health-related quality of life (HRQoL), psychological flexibility, cognitive fusion, sleep quality, and confidence. RESULTS: Overall, 99.3% of the included patients were assessed as having mild depression. The ACT intervention significantly reduced depression in acute stroke patients in comparison with the control group post-intervention and at 3 months (partial ). Additionally ACT significantly improved HRQoL-mental component summary, sleep quality, psychological flexibility, cognitive fusion, and confidence compared with control group. CONCLUSIONS: ACT is effective in treating acute stroke patients with depression, and the efficacy was maintained at 3-month follow-up.
目的:迄今为止,接受和承诺疗法(ACT)对急性脑卒中患者的疗效尚未得到充分认可。本研究旨在探讨基于团体的 ACT 对急性脑卒中后抑郁患者的疗效。
方法:我们开展了一项随机对照试验,纳入了 140 例患有抑郁的急性脑卒中患者。ACT 干预包括 7 次、每次 45-60 分钟、持续 4 周。在干预前、干预后和 3 个月随访时收集数据,评估抑郁、健康相关生活质量(HRQoL)、心理灵活性、认知融合、睡眠质量和信心。
结果:总体而言,纳入的患者中有 99.3%被评估为轻度抑郁。与对照组相比,ACT 干预后和 3 个月时急性脑卒中后抑郁患者的抑郁程度显著降低(部分η²=0.26,P<0.001)。此外,与对照组相比,ACT 显著改善了 HRQoL 心理成分综合评分、睡眠质量、心理灵活性、认知融合和信心。
结论:ACT 治疗急性脑卒中后抑郁患者有效,且在 3 个月随访时疗效仍维持。
Br J Clin Psychol. 2018-7-12
J Stroke Cerebrovasc Dis. 2022-2
BMC Complement Med Ther. 2023-10-6
Gastroenterology. 2018-11-16
Health Technol Assess. 2019-9
J Stroke Cerebrovasc Dis. 2022-2
J Neurol. 2022-3
J Affect Disord. 2019-9-10